Published in Women's Health Weekly, February 17th, 2005
The intention is to bring new clinically well-documented products to market carrying a significant value to our customers
These three inlicensed technologies are:
Statins as a stimulant factor in in vitro maturation of human occytes (IVM). Recent discoveries by scientists at the renowned Laboratory of Reproductive Biology, Rigshospitalet University Hospital in Copenhagen, indicate that inhibitors of the cholesterol metabolism stimulate Meiosis and improve fertility in mice. Through the license agreement MediCult...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.